Neutral
This article argues that investors should consider Pfizer (NYSE:PFE) over Eli Lilly (NYSE:LLY), especially given current market volatility. While Eli ...
Eli Lilly EVP Ilya Yuffa sold 2,500 shares of common stock at an average price of $1,150.77 per share on June 10, 2026, as part of a pre-arranged Rule...
Abridge, an AI clinical assistant company, has secured a strategic investment from Eli Lilly and expanded its platform to integrate payer and life sci...
This SEC filing is a Form 144 Notice of Proposed Sale of Securities for ELI LILLY & Co (LLY). The filing indicates an intent to sell 2500 shares of co...
Eli Lilly's stock reached a new record high following positive data released for its next-generation weight-loss drug, retatrutide. This development h...
Eli Lilly and Co (LLY) experienced a 3.37% stock increase on June 8, driven by positive late-stage clinical trial results for its investigational trip...
Neutral
Prudent Man Advisors LLC grew its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 103.3% during the fourth quarter, according to its most r...
Neutral
Havemeyer Place LP bought a new position in Eli Lilly and Company (NYSE:LLY – Free Report) in the fourth quarter, according to its most recent disclos...
Eli Lilly and Co (LLY) stock rose by 3.15% due to several positive developments. These include CVS Caremark expanding coverage for Eli Lilly's obesity...
Bullish
Eli Lilly and Company saw its stock jump 5.5% to close at $1138.08, contributing to a sector-wide rally in pharmaceutical stocks. The surge added to t...
Eli Lilly and Co (LLY) stock rose by 3.56% due to promising clinical trial results for its new weight-loss drug retatrutide and cancer drug Retevmo, a...
Neutral
Eli Lilly has issued an ultimatum to hospitals and medical groups participating in the 340B drug discount program, requiring them to comply with data ...
Bullish
Eli Lilly and Company (LLY) is highlighted as one of the top stocks to buy according to AI, ranking 4th on Insider Monkey's list. The pharmaceutical g...
Bullish
Eli Lilly and Company is ranked among the top stocks to buy according to AI, driven by its strong performance in cardiometabolic health with Mounjaro ...
Neutral
Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 3.2% ...
Neutral
Waterloo Capital L.P. boosted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 17.8% during the fourth quarter, according to the company...
Neutral
Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 3.2% in the fourth quar...
Bullish
Eli Lilly and Company (LLY) is highlighted as a promising long-term stock, especially after positive Phase 1b Heart-2 study results for its VERVE-102 ...
Neutral
National Pension Service boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.5% in the 4th quarter, according to the company i...
Bullish
The article highlights bullish sentiments from financial analysts on three healthcare stocks: Eli Lilly & Co (LLY), Corbus Pharmaceuticals (CRBP), and...